Teva gains $400M investment from Blackstone Life Sciences to advance duvakitug
Source: SeekingAlpha
2026-03-03 17:32:49 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results - Slideshow
- Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results Transcript
- Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript
- Teva, Medincell granted FDA review for long-acting antipsychotic
- Corcept falls as appeals court sides with Teva in Korlym patent dispute
Read the full article on Seeking Alpha
For further details see:
Teva gains $400M investment from Blackstone Life Sciences to advance duvakitug
Sanofi
NASDAQ: SNY
SNY Trading
-0.56% G/L:
$44.155 Last:
1,077,036 Volume:
$44.07 Open:
SNY Latest News
February 23, 2026 01:42:29 pm
Kraig Biocraft Laboratories Featured on the Cover of National Geographic
February 18, 2026 08:45:56 am
It's Not Synthetic, It's Real. Kraig Labs Nears Spider Silk Breakthrough
SNY Stock Data
$119,804,457,217
2,430,957,423
N/A
389
N/A
Pharmaceuticals
Healthcare
FR
Paris
